Homa Bahrami Sells 2,500 Shares of Fabrinet (NYSE:FN) Stock

Fabrinet (NYSE:FNGet Free Report) Director Homa Bahrami sold 2,500 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $711.91, for a total transaction of $1,779,775.00. Following the sale, the director directly owned 16,233 shares of the company’s stock, valued at $11,556,435.03. The trade was a 13.35% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Fabrinet Stock Up 0.4%

NYSE:FN opened at $705.89 on Friday. Fabrinet has a 52 week low of $222.66 and a 52 week high of $748.89. The firm has a 50 day moving average of $622.90 and a 200 day moving average of $529.44. The stock has a market capitalization of $25.29 billion, a price-to-earnings ratio of 60.64 and a beta of 1.22.

Fabrinet (NYSE:FNGet Free Report) last posted its earnings results on Monday, May 4th. The technology company reported $3.72 EPS for the quarter, beating analysts’ consensus estimates of $3.58 by $0.14. Fabrinet had a net margin of 9.94% and a return on equity of 19.83%. The company had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter in the prior year, the company posted $2.52 earnings per share. Fabrinet’s revenue for the quarter was up 39.3% compared to the same quarter last year. Fabrinet has set its Q4 2026 guidance at 3.720-3.870 EPS. As a group, analysts expect that Fabrinet will post 12.96 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently commented on FN. Barclays increased their target price on shares of Fabrinet from $548.00 to $702.00 and gave the company an “overweight” rating in a research report on Tuesday, May 5th. JPMorgan Chase & Co. cut their price target on shares of Fabrinet from $700.00 to $680.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Needham & Company LLC restated a “buy” rating and set a $800.00 price target on shares of Fabrinet in a research note on Tuesday, May 5th. Weiss Ratings upgraded shares of Fabrinet from a “hold (c+)” rating to a “buy (b)” rating in a research note on Wednesday, May 6th. Finally, B. Riley Financial upped their price target on shares of Fabrinet from $366.00 to $452.00 and gave the company a “neutral” rating in a research note on Tuesday, February 3rd. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Fabrinet has a consensus rating of “Moderate Buy” and a consensus target price of $661.75.

Get Our Latest Stock Analysis on Fabrinet

Institutional Trading of Fabrinet

Hedge funds and other institutional investors have recently made changes to their positions in the business. Core Wealth Advisors LLC acquired a new stake in shares of Fabrinet in the fourth quarter worth $25,000. Westend Capital Management LLC acquired a new stake in shares of Fabrinet in the fourth quarter worth $29,000. Harbour Investments Inc. increased its stake in shares of Fabrinet by 75.0% in the fourth quarter. Harbour Investments Inc. now owns 63 shares of the technology company’s stock worth $29,000 after acquiring an additional 27 shares during the period. Cassaday & Co Wealth Management LLC acquired a new stake in shares of Fabrinet in the first quarter worth $31,000. Finally, Creative Financial Designs Inc. ADV acquired a new stake in shares of Fabrinet in the fourth quarter worth $32,000. Institutional investors and hedge funds own 97.38% of the company’s stock.

Fabrinet Company Profile

(Get Free Report)

Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.

Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.

Featured Stories

Insider Buying and Selling by Quarter for Fabrinet (NYSE:FN)

Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.